The MiniMed continuous glucose monitoring system (CGMS)

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue SUPPL. 3, 1999, Pages 751-758

  Mastrototaro, John ^a  

^a MiniMed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALIBRATION; CONFERENCE PAPER; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; PATIENT MONITORING; SENSOR;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 0033431643     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. Jaremko J, Otto R. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998; 21: 444-450.
3. Cote GL, Fox MD, Northrop RB. Non-invasive optical polarimetric glucose sensing using a true phase measurement technique. IEEE Trans Biomed Eng 1992; 39: 752-756.
4. Tan RV. The non-invasive measure of D-glucose in the ocular aqueous humor using stimulated Raman spectroscopy. Ph.D. Thesis, Georgia Institute of Technology, 1991.
5. Arnold MA. Non-invasive glucose monitoring. Curr Opin Biotechnol 1996; 7: 46-49.
6. Robinson MR, Eaton RP, Haaland DM, Koepp GW, Thomas EV, Stallard BR, Robinson PI. Non-invasive glucose monitoring in diabetic patients: a preliminary evaluation. Clin Chem 1992; 38: 1618-1622.
7. Bruulsema JT, Hayward JE, Farrell TJ, Patterson, MS. Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient. Optics Lett 1997; 22: 190-192.
8. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes 1990; 39: 1519-1526.
9. Tamada JA, Bohannon NJ, Potts RO. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nature Med 1995; 1; 1198-1201.
10. Bolinder J, Ungerstedt U, Arner P. Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet 1993; 342: 1080-1085.
11. Poitout V, Moatti-Sirat D, Reach G, Zhang Y, Wilson GS, Lemonnier F, Klein JC. A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit. Diabetologia 1993; 36: 658-666.
12. Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H. Closed-loop glycaemic control with a wearable artificial endocrine pancreas. Diabetes 1984; 33: 1200-1202.
13. Pfeiffer EF. On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. Diabetologia 1987; 30: 51-65.
14. Bantle J, Thomas W. Glucose monitoring using dermal interstitial fluid. Diabetes 1997; 46A: 619.
15. Sternberg F, Meyerhoff C, Mennel FJ, Mayer H, Bischof F, Pfeiffer EF. Does fall in tissue glucose precede fall in blood glucose? Diabetologia 1996; 39: 609-612.
16. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. Diabetes Care 1995; 18: 517-522.
17. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counter-regulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med 1987; 316: 1376-1383.
18. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 1994; 37: 1265-1276.
19. Bolli GB. Counterregulatory mechanisms to insulin-induced hypoglycemia in humans: relevance to the problem of intensive treatment of IDDM. J Pediatr Endocrinol Metab 1998; 11 (Suppl 1): 103-115.